Cardiovascular function in secondary pulmonary hypertension.
D001993:Bronchodilator Agents / Q000627:therapeutic use; D002319:Cardiovascular System / Q000503:physiopathology*; D004070:Digitalis; D004232:Diuretics / Q000627:therapeutic use; D004452:Echocardiography; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D008168:Lung / Q000000981:diagnostic imaging; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000503:physiopathology; D010102:Oxygen Inhalation Therapy; D005082:Physical Exertion; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011379:Prognosis; D011651:Pulmonary Artery / Q000503:physiopathology; D011660:Pulmonary Heart Disease / Q000209:etiology / Q000503:physiopathology; D011859:Radiography; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012146:Rest; D013793:Thallium; D014665:Vasodilator Agents / Q000627:therapeutic use
D001993:Bronchodilator Agents; D004232:Diuretics; D011868:Radioisotopes; D014665:Vasodilator Agents; D013793:Thallium